| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.9M | +16.7% |
| Cost of Revenue | $10.8M | +42.0% |
| Gross Profit | $4.0M | -21.1% |
| R&D Expense | $3.7M | +5.3% |
| SG&A Expense | $3.4M | +11.7% |
| Operating Income | -$6.0M | -27.5% |
| Pre-tax Income | -$10.1M | -100.0% |
| Income Tax | -$13K | -30.0% |
| Net Income | -$11.7M | -90.1% |
| EPS (Basic) | -$0.18 | -63.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $815K | -40.8% |
| Short-term Investments | $105K | +0.0% |
| Accounts Receivable | $3.3M | +185.2% |
| Inventory | $3.2M | +29.1% |
| Current Assets | $8.4M | -30.5% |
| Total Assets | $12.5M | -26.2% |
| Current Liabilities | $11.3M | +3.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $247K | -39.3% |
| Long-term Debt |
| $26K |
| +73.3% |
| Total Liabilities | $14.0M | -1.7% |
| Stockholders' Equity | -$1.5M | -155.5% |